Looking Back: ACRO Biotech’s Moments at ADLM 2026

We have successfully concluded our participation in ADLM 2026, which took place from July 28 to 30, 2026 at the Anaheim Convention Center in California, the United States. We welcomed numerous valued partners and industry peers at our Booth 1942 throughout the whole exhibition period, sharing our advanced laboratory diagnostic technologies and newly released product ranges together.

The ADLM Annual Scientific Meeting & Clinical Lab Expo brought together top professionals and enterprises from the global laboratory medicine and in vitro diagnostics industries. It acted as a premium communication platform for academic exchanges and technical discussions about innovative breakthroughs that advance the future of clinical laboratory testing.

During the three-day show, ACRO Biotech fully displayed a complete series of newly launched products that we had developed over the past ten years of research and development work. Our exhibited offerings fell into six core product segments. Firstly, our New DOA Rapid Test Kits were showcased, supporting the detection of various substances including Scopolamine (SCOP), Citalopram (CIT), Mirtazapine (MTZ), N,N-Dimethyltryptamine (NND), Tapentadol (TAP), Etomidate (ETO), Fentanyl (FYL), Fluoketamine (FKET) and Paroxetine (PRT). Secondly, our Fluorescence Immunoassay Tests were presented, covering key biomarkers such as Troponin I, Myoglobin, CK-MB, Prolactin, FT4, FT3, AMH, HbA1c and Vitamin D. Thirdly, our Infectious Disease Rapid Test Panels were exhibited, enabling rapid detection of Malaria, Dengue, Chagas, Chikungunya, Zika, Filariasis, Typhoid, Salmonella, Leishmania and Leptospira pathogens.

We also demonstrated our flagship diagnostic analytical instruments on site, namely the Blood Glucose/Ketone/Uric Acid/Cholesterol Monitoring Meter I, Handheld Fluorescence Immunoassay Analyzer and AltiSpeed Plus Urine Analyzer. All these devices were engineered to enhance diagnostic accuracy, simplify routine testing procedures, and assist clinical practitioners in obtaining stable and credible patient test outcomes efficiently.

Our experienced sales and technical team delivered live product demonstrations and tailored professional consulting services for every visiting guest at the booth. We consistently commit to developing user-friendly diagnostic testing solutions to satisfy varied clinical laboratory requirements.

We greatly cherished all the face-to-face communications and cooperation talks with partners at Booth 1942 during ADLM 2026. We will continue to innovate diagnostic products and look forward to deeper long-term collaboration with global partners in the future.